Nice update T7 But at the end of the day, the overpaid CEO will be judged by what she has not done after more than a decade at the helm of this company. Thats is, shareholders wealth has deteriorated every year and at this point in time is at an all time low. It seems like every week a company is revealing a new blood test with exciting promise, while 20 years of research and countless Midkine Symposiums have just been fruitless. If Midkine is going to be the Holy Grail, then why hasn’t a big name player signed on the dotted line by now?
CDY Price at posting:
27.5¢ Sentiment: None Disclosure: Not Held
